The care path, delivery, and follow-up all felt connected. More confidence in the whole routine Chloe F
The ASCO GI 2026 data suggest that GLP-1 therapy may be particularly relevant for metabolically high-risk populations, including individuals with obesity, insulin resistance, or type 2 diabetesgroups that now account for a substantial proportion of colorectal cancer burden
Sleep architecture: GHRH administration enhances slow-wave sleep duration in both young and elderly subjects (Steiger et al., 1992), supporting the PM dosing strategy
They had found seven healthy volunteers to hook up to IV bags containing a solution of GLP-1
This combined action explains why users report sustained appetite suppression rather than the temporary effect seen with older weight-loss medications that only affected metabolism or central appetite
Instead, it works on a cellular level to reduce fat storage and boost metabolism, making it suitable for those who prefer not to rely on appetite suppression for weight loss